Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | LPL | P06858 | 5/20 | 0.43 |
| ▸ | LIPG | Q9Y5X9 | 5/20 | 0.43 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.43 |
| ▸ | ESR1 | P03372 | 2/20 | 0.42 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.42 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.42 |
| ▸ | TACR2 | P21452 | 2/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.42 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.42 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | SHBG | P04278 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4208084 | 0.98 | KCNH2 (0.46) | TDP1L3MBTL1LPLLIPGKCNH2 | |
| SCHEMBL828059 | 0.98 | KCNH2 (0.46) | TDP1L3MBTL1LPLLIPGKCNH2 | |
| SCHEMBL533252 | 0.98 | KCNH2 (0.46) | TDP1L3MBTL1LPLLIPGKCNH2 | |
| SCHEMBL5210233 | 0.98 | KCNH2 (0.46) | TDP1L3MBTL1LPLLIPGKCNH2 | |
| SCHEMBL10602889 | 0.98 | KCNH2 (0.46) | TDP1L3MBTL1LPLLIPGKCNH2 | |
| SCHEMBL263493 | 0.98 | KCNH2 (0.46) | TDP1L3MBTL1LPLLIPGKCNH2 | |
| SCHEMBL5207581 | 0.98 | KCNH2 (0.46) | TDP1L3MBTL1LPLLIPGKCNH2 | |
| SCHEMBL4865067 | 0.98 | KCNH2 (0.46) | TDP1L3MBTL1LPLLIPGKCNH2 | |
| SCHEMBL20774553 | 0.98 | KCNH2 (0.46) | TDP1L3MBTL1LPLLIPGKCNH2 | |
| SCHEMBL5209751 | 0.98 | KCNH2 (0.46) | TDP1L3MBTL1LPLLIPGKCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 769 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024094125-A1 | LIPID COMPOUNDS, LIPID NANOPARTICLES, AND PHARMACEUTICAL COMPOSITIONS | Shanghai Circode Biomed Co., Ltd. (CN) | 2024-05-10 | — | — | WO | claimed |
| EP-3688124-B1 | ESTER COMPOUNDS, LUBRICATING OIL COMPOSITIONS CONTAINING SAME AND PROCESSES FOR MAKING SAME | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2023-10-25 | — | — | EP | claimed |
| US-11667674-B2 | Antibacterial cyclic lipopeptides | VERSITECH LIMITED (CN) | 2023-06-06 | — | — | US | claimed |
| CN-114889276-A | Flexible bistable thin film mechanism based on photoresponse and preparation method and application thereof | 东华大学 | 2022-08-12 | — | — | CN | claimed |
| CN-106232120-B | Process for preparing N-benzyl-3-hydroxy-4-substituted-pyridin-2- (1H) -ones | 爱尔皮奥治疗有限公司 | 2021-01-08 | — | — | CN | claimed |
| EP-3688124-A1 | ESTER COMPOUNDS, LUBRICATING OIL COMPOSITIONS CONTAINING SAME AND PROCESSES FOR MAKING SAME | ExxonMobil Chemical Patents Inc. (US) | 2020-08-05 | — | — | EP | claimed |
| US-10711216-B2 | Ester compounds, lubricating oil compositions containing same and processes for making same | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2020-07-14 | — | — | US | claimed |
| CN-111386331-A | Ester compound, lubricating oil composition containing same, and method for producing same | 埃克森美孚化学专利公司 | 2020-07-07 | — | — | CN | claimed |
| CN-111100045-A | Synthetic method of alkenyl sulfone compound | 中国科学技术大学 | 2020-05-05 | — | — | CN | claimed |
| US-20190100710-A1 | Ester Compounds, Lubricating Oil Compositions Containing Same and Processes for Making Same | EXXONMOBIL CHEMICAL PATENTS INC. | 2019-04-04 | — | — | US | claimed |
| EP-1586571-A1 | Dipeptidyl peptidase inhibitors | Takeda San Diego, Inc. (US) | 2005-10-19 | — | — | EP | claimed |
| WO-2005095381-A1 | DIPEPTIDYL PEPTIDASE INHIBITORS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2005-10-13 | — | — | WO | claimed |
| WO-2005087752-A2 | SUBSTITUTED HYDROXYETHYLAMINE ASPARTYL PROTEASE INHIBITORS | ELAN PHARMACEUTICALS, INC. (US) | 2005-09-22 | — | — | WO | claimed |
| WO-2005087751-A2 | SUBSTITUTED HYDROXYETHYLAMINE ASPARTYL PROTEASE INHIBITORS | ELAN PHARMACEUTICALS, INC. (US) | 2005-09-22 | — | — | WO | claimed |
| WO-2005070407-A1 | METHODS OF TREATMENT OF AMYLOIDOSIS USING ASPARTYL-PROTEASE INIHIBITORS | ELAN PHARMACEUTICALS, INC. (US) | 2005-08-04 | — | — | WO | claimed |
| WO-2005030751-A2 | DIPEPTIDYL PEPTIDASE INHIBITORS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2005-04-07 | — | — | WO | claimed |
| US-20050065144-A1 | Dipeptidyl peptidase inhibitors | SYRRX, INC. | 2005-03-24 | — | — | US | claimed |
| US-20050065145-A1 | Dipeptidyl peptidase inhibitors | SYRRX, INC. | 2005-03-24 | — | — | US | claimed |
| WO-2005026148-A1 | DIPEPTIDYL PEPTIDASE INHIBITORS | TAKEDA SAN DIEGO, INC. (US) | 2005-03-24 | — | — | WO | claimed |
| EP-1104677-A2 | Proteinconjugates and their preparation | Aventis Research & Technologies GmbH & Co. KG (DE) | 2001-06-06 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050065144-A1 | Dipeptidyl peptidase inhibitors | DPP4, DPP3, DPP7 | TDP1 1947/4885L3MBTL1 3168/4885LPL 83/4885 |
| US-20050065145-A1 | Dipeptidyl peptidase inhibitors | DPP4, DPP3, DPP7 | TDP1 1770/4885L3MBTL1 3196/4885LPL 96/4885 |
| US-11667674-B2 | Antibacterial cyclic lipopeptides | PTMS, NRDC, LNPEP | TDP1 4352/4885L3MBTL1 1076/4885LPL 40/4885 |
| US-10711216-B2 | Ester compounds, lubricating oil compositions containing same and processes for making same | ELOVL1, NOTUM, ELOVL5 | TDP1 1178/4885L3MBTL1 3530/4885LPL 111/4885 |
| US-20190100710-A1 | Ester Compounds, Lubricating Oil Compositions Containing Same and Processes for Making Same | ELOVL1, NOTUM, ELOVL5 | TDP1 1178/4885L3MBTL1 3530/4885LPL 111/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.